{
    "organizations": [],
    "uuid": "a88763e135099fb458668cba74a85996718c3612",
    "author": "Betsy McKay",
    "url": "https://www.wsj.com/articles/iqos-cigarette-alternative-gets-mixed-reception-from-fda-panel-1516907799",
    "ord_in_thread": 0,
    "title": "IQOS Cigarette Alternative Fares Poorly Before FDA Panel",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Scientists advising U.S. regulators dealt a setback to the tobacco industry’s multibillion-dollar quest to bring a cigarette alternative to market, saying there wasn’t enough evidence a hand-held device that heats but doesn’t burn tobacco reduces the risks of tobacco-related disease.\nThe advisory committee to the Food and Drug Administration said scientific evidence was insufficient to support an ambitious marketing claim proposed by Philip Morris International Inc. for the U.S. market. The claim said switching completely... To Read the Full Story Subscribe Sign In",
    "published": "2018-01-26T00:11:00.000+02:00",
    "crawled": "2018-01-26T01:01:30.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "scientist",
        "advising",
        "regulator",
        "dealt",
        "setback",
        "tobacco",
        "industry",
        "quest",
        "bring",
        "cigarette",
        "alternative",
        "market",
        "saying",
        "enough",
        "evidence",
        "device",
        "heat",
        "burn",
        "tobacco",
        "reduces",
        "risk",
        "disease",
        "advisory",
        "committee",
        "food",
        "drug",
        "administration",
        "said",
        "scientific",
        "evidence",
        "insufficient",
        "support",
        "ambitious",
        "marketing",
        "claim",
        "proposed",
        "philip",
        "morris",
        "international",
        "market",
        "claim",
        "said",
        "switching",
        "completely",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}